🇺🇸 FDA
Patent

US 8945544

Immunogenic compositions comprising progastrin and uses thereof

granted A61PA61P35/00

Quick answer

US patent 8945544 (Immunogenic compositions comprising progastrin and uses thereof) held by The Board of Regents of the University of Texas System expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61P, A61P35/00